(Q24244129)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15846731%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

0 references

1 reference

title

Sulfasalazine for ankylosing spondylitis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15846731%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

1 reference

ankylosing spondylitis

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15846731%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

author name string

J Chen

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15846731%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

publication date

18 April 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15846731%20AND%20SRC:MED&resulttype=core&format=json

Cochrane Database of Systematic Reviews

11 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15846731%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15846731%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

page(s)

CD004800

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15846731%20AND%20SRC:MED&resulttype=core&format=json

Comparison of sulfasalazine and placebo in the treatment of ankylosing spondylitis. A Department of Veterans Affairs Cooperative Study

11 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004800.PUB2

Sulphasalazine in ankylosing spondylitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004800.PUB2

Sulfasalazine in ankylosing spondylitis: a prospective, randomized, double-blind placebo-controlled study and comparison with other controlled studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004800.PUB2

Sulphasalazine in ankylosing spondylitis. A radiological, clinical and laboratory assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004800.PUB2

A 26 week randomised, double blind, placebo controlled exploratory study of sulfasalazine in juvenile onset spondyloarthropathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004800.PUB2

Comparison of sulfasalazine and placebo for the treatment of axial and peripheral articular manifestations of the seronegative spondylarthropathies: a Department of Veterans Affairs cooperative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004800.PUB2

Guidelines for the management of rheumatoid arthritis: 2002 Update

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004800.PUB2

Development and preselection of criteria for short term improvement after anti-TNF alpha treatment in ankylosing spondylitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004800.PUB2

Risk-Benefit Assessment of Drugs Used in the Treatment of Inflammatory Bowel Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004800.PUB2

Update on spondyloarthropathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004800.PUB2

Seronegative spondyloarthritides

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004800.PUB2

Sulphasalazine and mesalazine: serious adverse reactions re-evaluated on the basis of suspected adverse reaction reports to the Committee on Safety of Medicines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004800.PUB2

Ankylosing spondylitis: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004800.PUB2

Ankylosing spondylitis assessment group preliminary definition of short-term improvement in ankylosing spondylitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004800.PUB2

7 January 2021

Sulfasalazine in the treatment of ankylosing spondylitis. A twenty-six-week, placebo-controlled clinical trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004800.PUB2

7 January 2021

Sulfasalazine in the treatment of spondylarthropathy. A randomized, multicenter, double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004800.PUB2

7 January 2021

Which is the active moiety of sulfasalazine in ankylosing spondylitis? A randomized, controlled study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004800.PUB2

7 January 2021

Spondylarthropathy treatment: progress in medical treatment, physical therapy and rehabilitation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004800.PUB2

7 January 2021

Sulfasalazine in the prevention of anterior uveitis associated with ankylosing spondylitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004800.PUB2

7 January 2021

Sulphasalazine therapy in ankylosing spondylitis: its effect on disease activity, immunoglobulin A and the complex immunoglobulin A-alpha-1-antitrypsin

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004800.PUB2

7 January 2021

A controlled trial of sulphasalazine treatment of chronic ankylosing spondylitis: failure to demonstrate a clinical effect

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004800.PUB2

7 January 2021

THE COURSE OF ESTABLISHED ANKYLOSING SPONDYLITIS AND THE EFFECTS OF SULPHASALAZTh OVER 3 YEARS

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004800.PUB2

7 January 2021

New treatment strategies in ankylosing spondylitis: Proceedings of the Ankylosing Spondylitis Workshop, Berlin, Germany, 18-19 January 2002.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004800.PUB2

7 January 2021

Treatment trials in ankylosing spondylitis: current and future considerations.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004800.PUB2

7 January 2021

Conventional treatments for ankylosing spondylitis.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004800.PUB2

7 January 2021

10.1002/14651858.CD004800.PUB2

Identifiers

DOI

2 references

Consolidated OpenCitations Corpus – April 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15846731%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

1 reference

Consolidated OpenCitations Corpus – April 2017

2 references

Consolidated OpenCitations Corpus – April 2017